Group-based Stabilization and Skill Training for Patients With Lasting Posttraumatic Reactions in Mental Health Care
Launched by ST. OLAVS HOSPITAL · Mar 21, 2019
Trial Information
Current as of July 23, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new way to help people who are struggling with long-lasting reactions after experiencing traumatic events, such as stress disorders and other mental health issues. The researchers want to find out if adding a group-based stabilization and skill-training program to regular individual therapy can improve the well-being of patients. In this study, half of the participants will receive both the group program and their usual treatment, while the other half will only receive the usual individual therapy.
To be eligible for the trial, participants should be between the ages of 65 to 74 or 27 to 39, currently receiving treatment at outpatient clinics, and have experienced distressing events that have led to symptoms like feeling overly anxious, avoiding certain situations, or having trouble with emotions and relationships for at least six months. It’s important for participants to be able to understand and speak Norwegian to take part in the group activities. People with serious mental health issues, substance abuse problems, or those who have taken part in this program before will not be included in the study. If you join, you can expect to work in a supportive group setting, where you will learn skills to help manage your symptoms better alongside your regular therapy.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Receiving treatment in ordinary out-patient clinics
- • Having been exposed to or witnessing to traumatic event(s) defined as "one or several extremely threatening or horrific events or series of events or situations being of such a character which is likely to overwhelming distress in almost anyone in a similar situation", measured by Stressful Life Events Screening Questionnaire
- • Presenting with posttraumatic reactions such as hyperarousal, avoidance, intrusions, emotional dysregulation or interpersonal difficulties.
- • Symptom duration for a minimum of six months.
- • Understand and speak Norwegian to an extent that is required to participate in a stabilization- and skill-training group.
- Exclusion Criteria:
- • Active psychotic symptoms.
- • Substance or drug addiction or abuse.
- • High suicidal risk considered by the individual therapist.
- • Having participated in the course previously.
About St. Olavs Hospital
St. Olavs Hospital is a leading healthcare institution located in Trondheim, Norway, renowned for its commitment to advancing medical research and improving patient care. As a key clinical trial sponsor, the hospital is dedicated to conducting innovative research across various therapeutic areas, fostering collaboration among multidisciplinary teams of healthcare professionals and researchers. With state-of-the-art facilities and a patient-centric approach, St. Olavs Hospital aims to enhance clinical outcomes and contribute to the global body of medical knowledge through rigorous and ethically conducted clinical trials.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Trondheim, , Norway
Patients applied
Trial Officials
Anne-Lise Løvaas
Study Director
St. Olavs Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials